Investor Relations
Financial calendar
- 14/11/24
Interim report, Q3 2024
- 06/02/25
Year-end report, Q4 2024
- 01/05/25
2024 Annual Report
Latest press releases
ExpreS2ion to present in upcoming investor and scientific events
Hørsholm, Denmark, 31 October2024 – ExpreS2ion Biotech Holding AB’s subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate in upcoming investor and scientific events, including BIO-Europe, the Protein & Antibody Engineering Summit Europe, a 2024 Third Quarter Results Webinar, and the LSX Investival Showcase.
Read moreThe Board of Directors of ExpreS2ion Biotech Holding AB (publ) has resolved on the record date for the reverse share split
Hørsholm, Denmark, 24 October 2024 - At the Extraordinary General Meeting of ExpreS2ion Biotech Holding AB (publ) ("ExpreS2ion" or the "Company") on 21 October 2024, it was resolved on a reverse share split of the Company's shares, whereby forty (40) existing shares shall be consolidated into one (1) share (Sw. sammanläggning 1:40). The Board of…
Read moreBulletin from the Extraordinary General Meeting of ExpreS2ion Biotech Holding AB (publ)
Today, on 21 October 2024, ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") has held an Extraordinary General Meeting 2024 (the "EGM"). Notice of the EGM and complete proposals for resolutions taken are available on the Company's investor website, https://investor.expres2ionbio.com.
Read moreLatest presentations
BioStock Life Science
- From Seed To Success
16 September 2024
Presentation of
half-year results
15 August 2024
2024
Rights Issue Webinar
14 June 2024